Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Diabetes Care. 2011 Feb;34(2):430-6. doi: 10.2337/dc10-1002. Epub 2010 Oct 26.
Ectopic lipid storage in muscle (intramyocellular lipids [IMCL]) and liver (hepatocellular lipids [HCL]) coexists with impaired myocellular flux through ATP synthase (fATPase) in certain cohorts with increased risk of type 2 diabetes. Because women with a history of gestational diabetes mellitus (pGDM) have elevated ectopic lipids and diabetes risk, we tested whether deteriorated energy metabolism contributes to these abnormalities.
A total of 23 glucose-tolerant nonobese pGDM and eight women with normal glucose metabolism during pregnancy with similar age, body mass, and physical activity underwent oral glucose tolerance tests (OGTT) and intravenous glucose tolerance tests at 4-5 years after delivery. OGTT values <463 mL ⋅ min(-1) ⋅ m(-2) were considered to indicate insulin resistance. pGDM were further stratified into insulin-resistant (pGDM-IR) and insulin-sensitive (pGDM-IS) groups. IMCL, HCL, and fATPase were measured with (1)H/(31)P magnetic resonance spectroscopy.
pGDM had 36% higher fat mass and 12% lower insulin sensitivity. Log-transformed fATPase was lower in pGDM (10.6 ± 3.8 µmol ⋅ mL muscle(-1) ⋅ min(-1) vs. 12.1 ± 1.4 µmol ⋅ mL muscle(-1) ⋅ min(-1), P < 0.03) and related to plasma adiponectin after adjustment for body fat (r = 0.44, P < 0.04). IMCL were 61% and 69% higher in pGDM-IR (P < 0.05 vs. pGDM-IS) and insulin resistant women (P < 0.003 vs. insulin sensitive), respectively. HCL were doubled (P < 0.05) in pGDM and insulin resistant women, and correlated positively with body fat mass (r = 0.50, P < 0.01) and inversely with insulin sensitivity (r = -0.46, P < 0.05).
Glucose-tolerant pGDM show increased liver fat but only slightly lower muscular insulin sensitivity and ATP synthesis. This suggests that alteration of hepatic lipid storage represents an early and predominant abnormality in this cohort.
在某些 2 型糖尿病风险增加的人群中,肌肉内脂质(细胞内脂质[IMCL])和肝脏内脂质(肝细胞脂质[HCL])的异位脂质储存与肌细胞通过三磷酸腺苷合酶(fATPase)的通量受损并存。因为患有妊娠糖尿病史(pGDM)的女性异位脂质和糖尿病风险增加,我们检测了能量代谢恶化是否导致这些异常。
共有 23 名糖耐量正常的非肥胖 pGDM 和 8 名在妊娠期间血糖正常代谢且年龄、体重和体力活动相似的女性,在分娩后 4-5 年内接受口服葡萄糖耐量试验(OGTT)和静脉葡萄糖耐量试验。OGTT 值<463 mL ⋅ min(-1) ⋅ m(-2) 被认为表示胰岛素抵抗。pGDM 进一步分为胰岛素抵抗(pGDM-IR)和胰岛素敏感(pGDM-IS)组。用(1)H/(31)P 磁共振波谱法测量 IMCL、HCL 和 fATPase。
pGDM 的脂肪量增加 36%,胰岛素敏感性降低 12%。pGDM 的 log 转换 fATPase 较低(10.6 ± 3.8 µmol ⋅ mL 肌肉(-1) ⋅ min(-1) vs. 12.1 ± 1.4 µmol ⋅ mL 肌肉(-1) ⋅ min(-1),P < 0.03),与血浆脂联素相关,经体脂调整后(r = 0.44,P < 0.04)。pGDM-IR(P < 0.05 与 pGDM-IS)和胰岛素抵抗女性(P < 0.003 与胰岛素敏感)的 IMCL 分别高 61%和 69%。pGDM 和胰岛素抵抗女性的 HCL 均增加一倍(P < 0.05),并与体脂肪量呈正相关(r = 0.50,P < 0.01),与胰岛素敏感性呈负相关(r = -0.46,P < 0.05)。
糖耐量正常的 pGDM 显示肝脏脂肪增加,但肌肉胰岛素敏感性和 ATP 合成仅略有降低。这表明在该队列中,肝脂质储存的改变代表了早期和主要的异常。